Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Cariprazine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cariprazine 3mg capsules
0402010AJAAABAB
|
Cariprazine | Cariprazine | Central Nervous System | 495 |
|
Cariprazine 1.5mg capsules
0402010AJAAAAAA
|
Cariprazine | Cariprazine | Central Nervous System | 416 |
|
Cariprazine 6mg capsules
0402010AJAAADAD
|
Cariprazine | Cariprazine | Central Nervous System | 253 |
|
Cariprazine 4.5mg capsules
0402010AJAAACAC
|
Cariprazine | Cariprazine | Central Nervous System | 215 |
|
Reagila 3mg capsules
0402010AJBBABAB
|
Reagila | Cariprazine | Central Nervous System | 18 |
|
Reagila 1.5mg capsules
0402010AJBBAAAA
|
Reagila | Cariprazine | Central Nervous System | 3 |
|
Reagila 4.5mg capsules
0402010AJBBACAC
|
Reagila | Cariprazine | Central Nervous System | No data available |
|
Reagila 6mg capsules
0402010AJBBADAD
|
Reagila | Cariprazine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.